STOCK TITAN

NextCure: Affinity reports 475,626-share stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

NextCure, Inc. (NXTC) is the issuer in an amended ownership report stating that Affinity Asset Advisors, LLC and Michael Cho each beneficially owned 475,626 common shares as of September 30, 2026, including 183,666 shares issuable upon warrant exercise. The warrants are subject to a 9.99% beneficial ownership limitation.

The securities are directly held by Affinity Healthcare Fund, LP. Affinity Asset Advisors, the Fund’s investment manager, exercises voting and investment power over them; Michael Cho, the Adviser’s managing member, may also be deemed a beneficial owner. The reported percentages use a 4,761,025-share calculation base, including 183,666 warrant shares; 4,577,359 common shares were outstanding as of August 15, 2026.

Beneficial ownership 475,626 shares Reported as of September 30, 2026; includes 183,666 shares issuable upon warrant exercise.
Warrant shares issuable 183,666 shares Included in the reported beneficial ownership and subject to the 9.99% limitation.
Beneficial ownership limitation 9.99% Applies to the warrants after giving effect to their exercise.
Common shares outstanding 4,577,359 shares As of August 15, 2026.
Ownership-percentage calculation base 4,761,025 shares The stated basis for the reported percentages, including 183,666 warrant shares after giving effect to the ownership limitation.
beneficial ownership limitation regulatory
"subject to a beneficial ownership limitation of 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
warrants financial
"shares issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
investment manager financial
"the investment manager of the Fund"
sole dispositive power regulatory
"Sole Dispositive Power 475,626.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NXTC shares did Affinity Asset Advisors and Michael Cho report?

They reported beneficial ownership of 475,626 NextCure common shares as of September 30, 2026, including 183,666 shares issuable upon exercise of warrants.

How does the NXTC warrant ownership cap work?

The warrants are subject to a 9.99% beneficial ownership limitation, measured against NextCure common shares outstanding immediately after giving effect to warrant exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





65343E207

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Affinity Asset Advisors, LLC
Signature:/s/ Andrew Weinstein
Name/Title:Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer
Date:11/13/2026
Michael Cho
Signature:/s/ Michael Cho
Name/Title:Michael Cho, Self
Date:11/13/2026

Keep reading